Boost for cancer research could help save lives and offer new hope for cancer patients
17th February, 2017
The $20 million funding for clinical trials in cancer patients announced by the Victorian Government today can help save lives and offers a new hope for those living with cancer, Association of Australian Medical Research Institutes President Professor Tony Cunningham AO says.
In addition to saving lives, the funding will be a good investment in Victoria’s future bottom line with an estimated 3:1 return on spending on health and medical research, Professor Cunningham said.
“Almost half of the clinical trials underway at AAMRI members in Australia are happening in Victoria, and Victorians should be proud of that,” Professor Cunningham said.
“Clinical trials are an important part of the translation process of getting critical medical research out of the laboratory and to the point where it is available to treat patients.
“This $20 million over four years from the Victorian Government will help the Victorian Comprehensive Cancer Centre (VCCC) alliance advance their clinical trials and help save the lives of cancer patients.”
Additionally, the Victorian Government announced $12.2 million in Victorian Cancer Agency funding, including the first ever Allied Health and Nursing Clinical Research Fellowship that will see a new project investigating how exercise can improve quality of life for lung cancer survivors.
Professor Cunningham thanked the Victorian Government for the funding, and also thanked the New South Wales Government on announcing a similar amount of cancer funding yesterday.
“The NSW Government yesterday committed $11.6 million to cancer research, including more than $4 million to investigate new treatments for cancers with poor survival rates such as pancreatic, lung, and ovarian cancers,” Professor Cunningham said.
“I especially congratulate my colleague Professor Roger Reddel from the Children’s Medical Research Institute, on the Westmead campus, who received a translational program grant of $3.75 million for his work at the ACRF International Centre for the Proteome of Human Cancer (ProCan™), part of former US Vice President Joe Biden’s Cancer Moonshot initiative.
“It’s wonderful to see state governments be so forward thinking by investing in health and medical research. The pharmaceuticals and medical devices sector is the best-performing smart industry in Australia, so it offers significant returns to state governments in employment terms.
“While our medical researchers work to save the lives of Australians, and those around the world, the economic benefits of their research are well known, and growing. Not only does this research lead to treatments that save lives, it also leads to reduced costs through improved diagnostics, leading to more targeted treatments and better understanding of conditions that can prevent them from occurring in the first place.”
Media Contact: Rebecca Thorpe, 0401 419 590, email@example.com.